Fundraising Fox

OtoNexus Medical Technologies

Seattle, US · Delaware corporation · 2 known investors

Healthtech

Founders & leadership

CCCaitlin Cameron
Caitlin CameroninExecutive
MA
Mark A. MoehringNamed on SEC filing
GA
George A. GatesNamed on SEC filing

Board

HB
Harris BrodyBoard director
RF
Rhonda F. RhyneBoard director
MR
Marion R. FooteBoard director

Investors · 2

Keiretsu CapitalreportedSeattle
Keiretsu ForumreportedSan Francisco · $250K – $2M

Reported raises · per SEC filings

Form D private placements

$44.3M disclosed across 5 rounds · 2015–2022

▶$12.9MraisedFeb 2024 · 114 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark A. MoehringDirector
  • Marion R. FooteDirector
  • George A. GatesExecutive Officer, Director
  • Caitlin CameronExecutive Officer, Director
  • Harris BrodyDirector
Offering amount
$15M
Amount sold
$12.9M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedJan 2022 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Harris BrodyDirector
  • Rhonda F. RhyneDirector
  • Caitlin CameronExecutive Officer, Director
  • Marion R. FooteDirector
  • George A. GatesExecutive Officer, Director
  • Mark A. MoehringDirector
Offering amount
$5M
Amount sold
$1.9M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.5MraisedJun 2021 · 190 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marion R. FooteDirector
  • Caitlin CameronExecutive Officer, Director
  • George A. GatesExecutive Officer, Director
  • Rhonda F. RhyneDirector
  • Harris BrodyDirector
  • Mark A. MoehringDirector
Offering amount
$28.2M
Amount sold
$19.5M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedJan 2017 · 80 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rhonda F. RhyneDirector
  • Mark A. MoehringDirector
  • Marion R. FooteDirector
  • Caitlin CameronExecutive Officer, Director
  • George A. GatesExecutive Officer, Director
  • Harris BrodyDirector
Offering amount
$9.2M
Amount sold
$7.8M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJun 2016 · 54 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark A. MoehringDirector
  • Harris BrodyDirector
  • Rhonda F. RhyneDirector
  • George A. GatesExecutive Officer, Director
  • Marion R. FooteDirector
  • Caitlin CameronExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2.2M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directorsprnewswire.com · Apr 2023OtoNexus Medical Technologies Receives Prestigious National Science Foundation Grantprnewswire.com · Mar 2023OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expoprnewswire.com · Nov 2020OtoNexus Medical Technologies Receives 4th Consecutive Funding Round from Keiretsu Capital - BioSpacebiospace.com · Jul 2020OtoNexus Medical Technologies locks in fundingventurecapitaljournal.com · Jul 2020Keiretsu Forum Northwest & Rockies | OtoNexus Medical Technologies Receives 4th Consecutive Funding Roundk4northwest.com

Frequently asked questions

Who are OtoNexus Medical Technologies's investors?
OtoNexus Medical Technologies's investors include Keiretsu Capital, Keiretsu Forum.
How much funding has OtoNexus Medical Technologies raised?
OtoNexus Medical Technologies has disclosed $44.3M raised across 5 rounds.
Where is OtoNexus Medical Technologies headquartered?
OtoNexus Medical Technologies is headquartered in Seattle, US.